Arcutis Biotherapeutics (ARQT) Net Margin (2022 - 2026)
Arcutis Biotherapeutics (ARQT) recorded Net Margin of 11.56% in Q2 2026, up 31.05 percentage points from -19.49% a year earlier and up 22.27 percentage points from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Net Margin (2022 - 2026) Analysis & Trends
On a TTM basis, Arcutis Biotherapeutics' Net Margin came in at 6.15% as of Jun 30, 2026, up 41.55 percentage points year-over-year; for FY2025, it was -4.29%, up 66.96 percentage points from FY2024.
- Annual Net Margin has increased for three straight years, with a three-year change of +8445.46 percentage points (FY2022 to FY2025).
- Across earlier years, Net Margin came in at -71.25% in FY2024 (+368.54 pp), -439.79% in FY2023 (+8009.97 pp) and -8449.76% in FY2022.
- Quarterly Net Margin has ranged from -14856.41% in Q3 2022 to 13.43% in Q4 2025 over the past five years.
- On a year-over-year basis, Net Margin has increased for 12 consecutive quarters, with an average year-over-year change of +108.78 percentage points over the last eight quarters.
- Across the past five years, year-over-year gain in Net Margin ran from 24.66 percentage points in Q3 2024 to 14738.95 percentage points in Q3 2023.
- Per Business Quant, the preceding three quarters came in at -10.72% (Q1 2026), 13.43% (Q4 2025) and 7.47% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Arcutis Biotherapeutics | 3.32 Bn | 2.60 Bn | 118.92 Mn | 11.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.56% |
| Mar 31, 2026 | -10.72% |
| Dec 31, 2025 | 13.43% |
| Sep 30, 2025 | 7.47% |
| Jun 30, 2025 | -19.49% |
| Mar 31, 2025 | -38.06% |
| Dec 31, 2024 | -15.12% |
| Sep 30, 2024 | -92.81% |
| Jun 30, 2024 | -169.59% |
| Mar 31, 2024 | -71.38% |
| Dec 31, 2023 | -490.05% |
| Sep 30, 2023 | -117.47% |
| Jun 30, 2023 | -1,367.84% |
| Mar 31, 2023 | -2,880.26% |
| Dec 31, 2022 | -2,432.25% |
| Sep 30, 2022 | -14,856.41% |
API Access
Arcutis Biotherapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();